Emily Weg
Overview
Explore the profile of Emily Weg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anderson A, Ho J, Hall E, Hannan R, Liao J, Louie A, et al.
Future Oncol
. 2024 Sep;
20(33):2573-2588.
PMID: 39258792
Metastatic renal cell carcinoma (RCC) can present with oligometastatic disease and/or develop oligoprogression following systemic therapy. Cytoreductive and focal metastasis-directed therapy options include resection, stereotactic ablative radiation and thermal ablation....
2.
Moran S, Cheng H, Weg E, Kim E, Chen D, Iravani A, et al.
Abdom Radiol (NY)
. 2024 Feb;
49(4):1288-1305.
PMID: 38386156
Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) is transforming the management of patients with prostate cancer. In appropriately selected patients, PSMA-PET offers superior sensitivity and specificity compared to conventional imaging (e.g.,...
3.
Loeb S, Cheng H, Paller C, Weg E, Johnson J, Gross L, et al.
Prostate Cancer Prostatic Dis
. 2024 Jan;
28(1):220-222.
PMID: 38172199
Background: Germline testing is important in prostate cancer and evaluation can be complex. Methods: We instituted a monthly multi-disciplinary virtual genetics tumor board (7/2021-3/2022). Participants and panelists were surveyed on...
4.
Chen J, Weg E, Liao J
Expert Rev Anticancer Ther
. 2023 Jan;
23(2):163-176.
PMID: 36718727
Introduction: The paradigm of focal therapy's role in metastatic patients is being challenged by evolving attitudes and emerging data. At the current time, specifically regarding prostate cancer, does the evidence...
5.
McKenney A, Weg E, Bale T, Wild A, Um H, Fox M, et al.
Adv Radiat Oncol
. 2023 Jan;
8(1):100916.
PMID: 36711062
Purpose: Pseudoprogression mimicking recurrent glioblastoma remains a diagnostic challenge that may adversely confound or delay appropriate treatment or clinical trial enrollment. We sought to build a radiomic classifier to predict...
6.
Nguyen B, Mota J, Nandakumar S, Stopsack K, Weg E, Rathkopf D, et al.
Eur Urol
. 2020 Apr;
78(5):671-679.
PMID: 32317181
Background: CDK12 genomic alterations occur in several tumor types, but little is known about their oncogenic role and clinical significance. Objective: To describe the landscape of CDK12 alterations across solid...